Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenqiang Shi

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Microbial Cell Factories|June 27, 2022
SHTXTHHly, an extracellular secretion platform for the preparation of bioactive peptides and proteins in Escherichia coliWen Zhu, Yang Wang, Liangyin Lv, et al.
Acta Pharmaceutica Sinica. B|May 30, 2023
Universal chimeric Fc<i>γ</i> receptor T cells with appropriate affinity for IgG1 antibody exhibit optimal antitumor efficacyWen Zhu, Yang Wang, Liangyin Lv, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 1, 2022
A novel anti-PD-L1/IL-15 immunocytokine overcomes resistance to PD-L1 blockade and elicits potent antitumor immunityWenqiang Shi, Liangyin Lv, Nan Liu, et al.
Human Reproduction (Oxford, England)|March 3, 2023
Whole exome sequencing in unexplained recurrent miscarriage families identified novel pathogenic genetic causes of euploid miscarriageXiyao Wang, Wenqiang Shi, Shaotong Zhao, et al.
Journal of Materials Chemistry. B|August 12, 2020
Photo-induced specific intracellular release EGFR inhibitor from enzyme/ROS-dual sensitive nano-platforms for molecular targeted-photodynamic combinational therapy of non-small cell lung cancerMan Zhang, Xuequan Zhang, Shengsheng Cai, et al.
Bioorganic & Medicinal Chemistry Letters|March 4, 2020
Synthesis and biological investigation of triazolopyridinone derivatives as potential multireceptor atypical antipsychoticsWenqiang Shi, Yu Wang, Chunhui Wu, et al.
Journal for Immunotherapy of Cancer|July 31, 2025
Universal Fab-Fc masked cytokine prodrug platform: αPD-L1/IL-15 prodrug activates CD44<sup>+</sup> CD8<sup>+</sup> T cells in tumor-draining lymph nodes to enhance antitumor immunityLuyao Song, Gen Qi, Wenqiang Shi, et al.
Applied Microbiology and Biotechnology|April 14, 2023
Oxidation and reduction analysis of therapeutic recombinant human interleukin-15 by HPLC and LC-MSYang Wang, Huanhuan Chen, Meiqi Zhao, et al.
The Journal of Organic Chemistry|December 31, 2019
Synthesis of CBD and Its Derivatives Bearing Various C4'-Side Chains with a Late-Stage Diversification MethodXudong Gong, Changliang Sun, Melkamu Alemu Abame, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 3, 2024
A tumor-conditional IL-15 safely synergizes with immunotherapy to enhance antitumor immune responsesWenqiang Shi, Wei Xu, Luyao Song, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Microbial Cell Factories|June 27, 2022
SHTXTHHly, an extracellular secretion platform for the preparation of bioactive peptides and proteins in Escherichia coliWen Zhu, Yang Wang, Liangyin Lv, et al.
Acta Pharmaceutica Sinica. B|May 30, 2023
Universal chimeric Fc<i>γ</i> receptor T cells with appropriate affinity for IgG1 antibody exhibit optimal antitumor efficacyWen Zhu, Yang Wang, Liangyin Lv, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 1, 2022
A novel anti-PD-L1/IL-15 immunocytokine overcomes resistance to PD-L1 blockade and elicits potent antitumor immunityWenqiang Shi, Liangyin Lv, Nan Liu, et al.
Human Reproduction (Oxford, England)|March 3, 2023
Whole exome sequencing in unexplained recurrent miscarriage families identified novel pathogenic genetic causes of euploid miscarriageXiyao Wang, Wenqiang Shi, Shaotong Zhao, et al.
Journal of Materials Chemistry. B|August 12, 2020
Photo-induced specific intracellular release EGFR inhibitor from enzyme/ROS-dual sensitive nano-platforms for molecular targeted-photodynamic combinational therapy of non-small cell lung cancerMan Zhang, Xuequan Zhang, Shengsheng Cai, et al.
Bioorganic & Medicinal Chemistry Letters|March 4, 2020
Synthesis and biological investigation of triazolopyridinone derivatives as potential multireceptor atypical antipsychoticsWenqiang Shi, Yu Wang, Chunhui Wu, et al.
Journal for Immunotherapy of Cancer|July 31, 2025
Universal Fab-Fc masked cytokine prodrug platform: αPD-L1/IL-15 prodrug activates CD44<sup>+</sup> CD8<sup>+</sup> T cells in tumor-draining lymph nodes to enhance antitumor immunityLuyao Song, Gen Qi, Wenqiang Shi, et al.
Applied Microbiology and Biotechnology|April 14, 2023
Oxidation and reduction analysis of therapeutic recombinant human interleukin-15 by HPLC and LC-MSYang Wang, Huanhuan Chen, Meiqi Zhao, et al.
The Journal of Organic Chemistry|December 31, 2019
Synthesis of CBD and Its Derivatives Bearing Various C4'-Side Chains with a Late-Stage Diversification MethodXudong Gong, Changliang Sun, Melkamu Alemu Abame, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 3, 2024
A tumor-conditional IL-15 safely synergizes with immunotherapy to enhance antitumor immune responsesWenqiang Shi, Wei Xu, Luyao Song, et al.
Pageof 6